Our mission is to improve outcomes and quality of life for people with schizophrenia spectrum disorders through research.
Through the collaboration of CAMH researchers, clinicians and clients, our research focuses on identifying the early signs of schizophrenia spectrum disorders, improving novel therapeutic treatment, bettering management of medication side-effects, enhancing patient recovery, and more. Overall, our program aims to better understand, treat and prevent schizophrenia.
Research Areas & Projects
Current projects and key areas of research in the Schizophrenia Clinical Division include:
Metabolic risk management
Genetics and pharmacogenetics
Youth psychosis and at-risk populations
Recovery and rehabilitation
Programs & Services Directory
Visit our Programs & Services Directory for information on clinical care, including youth psychosis prevention, early psychosis, inpatient and outpatient services and more.